US Wages Biological War Against China

Shocking news just in from India is enough to make one’s blood run cold. A professor of Molecular Biology in New Delhi’s Jawaharlal Nehru University, Anand Ranganathan, and his colleagues published a preprint (which has not been peer-reviewed as yet) about their research on the novel coronavirus (2019-nCoV) from China.   They discovered a possible link between it and other similar known coronaviruses circulating in animals (such as bats and snakes), and found HIV virus-like insertions in 2019-nCoV.   No other well-studied coronaviruses have such a structure. Hence, their research hints at the possibility that the virus was designed and could be used to wage biological warfare. China’s National Health Commission has reported 31,161 confirmed cases of coronavirus. And on 7 February, there were 31,452 individuals infected with 2019-nCoV worldwide, and 638 had succumbed to the disease.

In light of these recent developments, it seems apt to remind our readers that a fierce, take-no-prisoners type of trade war is currently ongoing between the United States and China. And in the midst of this confrontation, as if by a wave of a magic wand, a coronavirus outbreak started in the PRC, which has already caused enormous damage to the Chinese economy and has considerably weakened Beijing’s bargaining position at the negotiating table.

Bloomberg reported that Chinese stocks plummeted when markets reopened and called these developments “the worst rout since 2015.” For ten days China’s and Hong Kong’s financial markets had been closed on account of the Lunar New Year holiday celebrations nation-wide. And the more than 8% fall in key stock indices has been linked to the coronavirus outbreak.  Share prices of telecommunication, technology and extractive companies are decreasing the most. Crude oil, iron ore and ferrous metal futures fell by 7%, 6.5 % and 6 % respectively. Copper, and crude and palm oil also sank by the maximum daily limit allowed on the Chinese markets.  Fang Rui, the Managing Director at Shanghai WuSheng Investment Management Partnership, said: “A lot of people in the market have not been through situations like today, and you can’t blame people for wanting cash when they feel like their health is at risk.”

Even before the coronavirus outbreak, many experts reported that, recently, Washington, in contravention of international law, was actively developing biological weapons in its numerous laboratories located in the United States as well as abroad. In November of last year, Secretary of the Security Council of Russia Nikolai Patrushev, who is well-versed on the topic, sounded the alarm about this and described key threats to security of many nations of the world. One section of his article addressed policies “aimed at the destruction of the unified humanitarian space” and at sowing division within the CIS (the Commonwealth of Independent States) and the CSTO (the Collective Security Treaty Organization), and also referred to the establishment of laboratories by the United States in CIS countries. “Of particular concern are the Pentagon’s activities aimed at creating biological laboratories across the globe, first of all in CIS countries, which study infectious diseases and can be used to develop biological weapons,” Nikolai Patrushev wrote. Later on, there were reports that more than 200 U.S. biological laboratories began operations worldwide. And some are situated in Azerbaijan, Armenia, Georgia, Kazakhstan, Moldova, Uzbekistan and Ukraine.

In his comments about the research conducted by the Indian scientists, Igor Nikulin, a former advisor to the United Nations commission on chemical and biological weapons, pointed out that China’s medical staff had started treating individuals infected with the novel coronavirus with HIV medicines with some success.  In his interview with newspaper Moskovskij Komsomolets, he said that 2019-nCoV was a weaponized version of the coronavirus, and that there was not a shred of doubt it had been designed for a specific purpose. As scientists are working on a vaccine against this novel virus, medical workers remind the public that the same means for treating the flu should be used to fight this disease.

The main question is who benefits from the fact that yet another epidemic has put a powerful nation such as China off its stride. If we recall the famous “highly likely” tactic unceremoniously used by UK’s former Prime Minister Theresa May to tie the supposed poisoning of Skripal family members to Russia, then the answer to the aforementioned question is obvious: “The outbreak caused by the novel coronavirus (2019-nCoV) that struck China is most likely beneficial to the United States.” And the worse the situation is for Beijing, the better it is for Washington, especially since the outlook for the epidemic looks bleak for now. For example, some experts claim that if the efforts to stop the spread of the virus fail, 250 million residents of China could succumb to the disease!……more here

Click here for reuse options!
Copyright 2020 Hiram's 1555 Blog